Indoco Remedies Ltd. (Q2 FY27) Earnings Update

Indoco Remedies delivered a solid financial turnaround for the second quarter of FY27, marked by a return to bottom-line profitability and steady operational growth. The results indicate stabilized operations and improved cost management compared to the prior-year period. Key Financial Highlights Revenue Expansion: Revenue from operations grew 7.4% year-on-year to ₹507 crore, up from ₹472 crore in the corresponding quarter of the previous fiscal year. Return to Profitability: The company posted a net profit of ₹19.5 crore, marking a significant recovery from the net loss of ₹9.2 crore reported in Q2 of the prior year. Operating Performance: EBITDA increased by 10% year-on-year, reaching ₹33 crore compared to ₹30.2 crore a year ago. Margin Stability: The EBITDA margin saw a slight sequential improvement, expanding to 6.5% from 6.4% in the prior-year period. Market Reaction & Sentiment Following the earnings release, investor sentiment reacted positively, with Indoco Remedies shares surging 3.42% to trade at ₹227. Despite this post-earnings momentum, the stock remains marginally down by approximately 1% on a year-to-date basis for 2026. The return to net profitability provides a stronger baseline for the company's near-term outlook and operational execution.